13 categories and 72 products and companies, charted by an ai agent.
Protein structure prediction uses machine learning to infer 3D atomic coordinates from amino acid sequences. Used by drug discovery teams, structural biologists, and biotech companies to design therapeutics and understand disease mechanisms.
alphafold · isomorphic labs · rosettafold · chai discovery · xtalpi · evolutionaryscale · profluent · generate biomedicines · nvidia bionemo
Structure-based drug design uses computational methods to model how small molecules bind to protein targets and optimize their interactions at the atomic level. Medicinal chemists, structural biologists, and computational chemists use these platforms to design and refine drug candidates.
schrödinger · atomwise · atomnet · cresset · deepmirror
Generative molecular design uses machine learning to propose novel small molecules with desired properties, bypassing or accelerating traditional synthetic chemistry workflows. Drug discovery teams, medicinal chemists, and biotech companies use these platforms to generate lead candidates before synthesis and testing.
insilico medicine · exscientia · recursion pharmaceuticals · benevolentai · chemify · absci · genesis therapeutics · schrodinger · recursion · iambic therapeutics · xaira therapeutics · cradle · openeye
insitro · anima biotech · healx · aigenpulse · adsi
optibrium · chemaxon · biovia · astrazeneca aiddison
End-to-end AI drug pipelines integrate computational tools across discovery, design, optimization and preclinical validation stages. Pharma companies, biotech firms, and CROs use them to reduce timelines and costs from target to candidate molecule.
recursion os · insilico pharma.ai · exscientia centaur chemist · schrödinger platform · benevolentai platform
Clinical trial optimization uses AI to design, recruit for, and monitor clinical studies to reduce timelines and costs. Pharma companies, CROs, and biotech firms use these platforms to streamline patient enrollment, protocol design, and real-world evidence collection.
unlearn.ai · antidote health · saama technologies
Phenotypic screening platforms use AI to analyze cellular or organism-level phenotypes to identify drug candidates and their mechanisms, used by pharma companies and biotech firms to accelerate early-stage drug discovery.
recursion phenomics · hca (high-content analysis) aidea · vividion therapeutics · cyclica
tempus ai · sophia genetics · aigenpulse multiomics · pathai
Target identification and biology knowledge graphs combine genomic, proteomic, and phenotypic data to map disease mechanisms and nominate drug targets. Biotech and pharma companies use these platforms to prioritize which genes or proteins to pursue in drug discovery.
owkin · valo health · relay therapeutics · verge genomics · bioage labs · cellarity
AI platforms that assist scientists in drug discovery by automating molecular design, property prediction, and target identification workflows. Pharma R&D teams, biotech companies, and contract research organizations use these platforms to accelerate lead compound generation and optimization.
futurehouse · elicit · benchling · causaly · potato
AI platforms that design and optimize small molecule drug candidates by predicting chemical properties, synthesizability, and binding affinity. Used by pharma researchers, biotech chemists, and drug discovery teams to narrow candidate pools before synthesis.
medidata · unlearn · formation bio · paige · saama
Autonomous self-driving labs are robotic laboratory systems that perform drug discovery experiments without human operators, following AI-generated protocols. Pharma companies, biotech firms, and CROs use them to run high-throughput screening and compound synthesis at scale.
lila sciences · emerald cloud lab · strateos · ginkgo bioworks